CEBPA and acute myeloid leukemia: mRNAseq-based gene expression profiling showed the characteristic bi-allelic CEBPA mutation-associated signature for all four AML samples carrying two CEBPA mutations (2-009, 2-039, 2-045, and 3-003), including case 3-003 whose C-terminal mutation was missed by HAMLET (Fig. 3).